Letter re: “ECMO In trauma care: What you need to know”

To the Editor: I have been deeply engaged in contemplating the recent publication in the Journal of Trauma and Acute Care Surgery, titled “The Application of ECMO in Trauma Care: What You Need to Know.”1 This article provides a comprehensive review of extracorporeal membrane oxygenation (ECMO) utilization in trauma patients, offering valuable insights for clinical practice. However, when discussing ECMO's application in trauma care, I believe that it is imperative to delve further into the necessity of rigorous indications assessment. After all, ECMO, as a specialized treatment modality, while rescuing patients, may also incite a range of societal, ethical, and medical resource allocation dilemmas. Primarily, I must express genuine appreciation for the authors' meticulous analysis of ECMO in the realm of trauma care, particularly in precise application for critically injured patients. The article prominently emphasizes the significance of early consultation and prompt referral to ECMO-capable medical centers, exemplifying notable efficacy in adult and pediatric trauma management through practical cases. However, it is worth noting that these successful cases predominantly focus on young patients with blunt or penetrating injuries, typically devoid of severe underlying conditions or comorbidities. In scenarios predominantly necessitating respiratory and circulatory support with manageable bleeding, ECMO indeed substantially improves patient prognosis. Nevertheless, for elderly patients or those with multiple comorbidities, infections, or sepsis, the prognostic efficacy of ECMO may significantly diminish.2 Moreover, we must lucidly recognize that, despite ECMO's notable efficacy in certain specific cases, as an advanced and restrictive technique, its clinical application invariably encounters myriad challenges. Foremost, ECMO implementation entails substantial consumption of medical, economic, human, and societal resources, posing significant economic strain for numerous medical institutions. Consequently, when contemplating ECMO utilization, comprehensive consideration of its pros and cons is imperative to ensure judicious resource utilization. Simultaneously, owing to the finite nature and uneven geographical distribution of medical resources, many regions may encounter difficulties in providing adequate ECMO support. Given this, advocating for centralized treatment at regional ECMO centers with robust economic, human, and technical support is prudent for optimal therapeutic outcomes. Furthermore, ECMO application inevitably traverses a series of intricate ethical quandaries.3 When determining ECMO utilization, thorough consideration of patient autonomy and familial input is indispensable. For instance, in patients with severe brain injuries, while ECMO may marginally prolong life, it may also precipitate patients into persistent vegetative states, incurring enduring and burdensome responsibilities for families and society alike. Hence, meticulous evaluation of patient prognosis, familial caregiving capabilities, and genuine familial desires is pivotal to ensure treatment decisions perpetually adhere to ethical principles. In addition, ECMO application also confronts a spectrum of complex societal issues. Despite ECMO technology's potential to salvage select patients' lives to a certain extent, its exorbitant treatment costs and latent risks of complications may confer substantial economic, psychological, and societal burdens upon patients and their families. Therefore, comprehensive evaluation of ECMO technology's comprehensive pros and cons, along with proactive exploration of more cost-effective therapeutic alternatives, is warranted. Lastly, given the current technological landscape's inability to resolve ECMO's inherent challenges, such as exorbitant equipment and operational costs, as well as unpredictable complications arising from biocompatibility issues, rigorous comprehensive assessments and profound contemplation are essential when using ECMO in clinical practice.4 Optimal medical care should incessantly aspire toward thoroughly curing patients in the simplest, most effective, and economically viable manner possible. If significant advancements can be achieved in elevating trauma patients' overall therapeutic outcomes and prognoses through continual improvement and optimization of alternative therapeutic modalities, it undoubtedly represents a collective and aspirational objective we all eagerly strive for. Li Deng, MDDepartment of Cardiovascular SurgeryGaozhou People's Hospital, GaozhouGuangdong, ChinaQingping Xia, MMCollege of Life Science, Mudanjiang Medical University, Mudanjiang CityHeilongjiang Province, ChinaLiangqing Zhang, MDDepartment of anesthesiologySecond Affiliated Hospital of Guangdong Medical University, ZhanjiangGuangdong Province, China

Authors

Institutions

Publication Details

Journal
The Journal of Trauma: Injury, Infection, and Critical Care
Published
2024-10-28
DOI
https://doi.org/10.1097/ta.0000000000004459
Primary Topic
Mechanical Circulatory Support Devices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Letter re: “ECMO In trauma care: What you need to know”

Qingping Xia, Li Deng, Liangqing Zhang
1 links
The Journal of Trauma: Injury, Infection, and Critical Care
Mechanical Circulatory Support Devices
article

Letter re: “ECMO In trauma care: What you need to know”

Qingping Xia, Li Deng, Liangqing Zhang
article en

Abstract

To the Editor: I have been deeply engaged in contemplating the recent publication in the Journal of Trauma and Acute Care Surgery, titled “The Application of ECMO in Trauma Care: What You Need to Know.”1 This article provides a comprehensive review of extracorporeal membrane oxygenation (ECMO) utilization in trauma patients, offering valuable insights for clinical practice. However, when discussing ECMO's application in trauma care, I believe that it is imperative to delve further into the necessity of rigorous indications assessment. After all, ECMO, as a specialized treatment modality, while rescuing patients, may also incite a range of societal, ethical, and medical resource allocation dilemmas. Primarily, I must express genuine appreciation for the authors' meticulous analysis of ECMO in the realm of trauma care, particularly in precise application for critically injured patients. The article prominently emphasizes the significance of early consultation and prompt referral to ECMO-capable medical centers, exemplifying notable efficacy in adult and pediatric trauma management through practical cases. However, it is worth noting that these successful cases predominantly focus on young patients with blunt or penetrating injuries, typically devoid of severe underlying conditions or comorbidities. In scenarios predominantly necessitating respiratory and circulatory support with manageable bleeding, ECMO indeed substantially improves patient prognosis. Nevertheless, for elderly patients or those with multiple comorbidities, infections, or sepsis, the prognostic efficacy of ECMO may significantly diminish.2 Moreover, we must lucidly recognize that, despite ECMO's notable efficacy in certain specific cases, as an advanced and restrictive technique, its clinical application invariably encounters myriad challenges. Foremost, ECMO implementation entails substantial consumption of medical, economic, human, and societal resources, posing significant economic strain for numerous medical institutions. Consequently, when contemplating ECMO utilization, comprehensive consideration of its pros and cons is imperative to ensure judicious resource utilization. Simultaneously, owing to the finite nature and uneven geographical distribution of medical resources, many regions may encounter difficulties in providing adequate ECMO support. Given this, advocating for centralized treatment at regional ECMO centers with robust economic, human, and technical support is prudent for optimal therapeutic outcomes. Furthermore, ECMO application inevitably traverses a series of intricate ethical quandaries.3 When determining ECMO utilization, thorough consideration of patient autonomy and familial input is indispensable. For instance, in patients with severe brain injuries, while ECMO may marginally prolong life, it may also precipitate patients into persistent vegetative states, incurring enduring and burdensome responsibilities for families and society alike. Hence, meticulous evaluation of patient prognosis, familial caregiving capabilities, and genuine familial desires is pivotal to ensure treatment decisions perpetually adhere to ethical principles. In addition, ECMO application also confronts a spectrum of complex societal issues. Despite ECMO technology's potential to salvage select patients' lives to a certain extent, its exorbitant treatment costs and latent risks of complications may confer substantial economic, psychological, and societal burdens upon patients and their families. Therefore, comprehensive evaluation of ECMO technology's comprehensive pros and cons, along with proactive exploration of more cost-effective therapeutic alternatives, is warranted. Lastly, given the current technological landscape's inability to resolve ECMO's inherent challenges, such as exorbitant equipment and operational costs, as well as unpredictable complications arising from biocompatibility issues, rigorous comprehensive assessments and profound contemplation are essential when using ECMO in clinical practice.4 Optimal medical care should incessantly aspire toward thoroughly curing patients in the simplest, most effective, and economically viable manner possible. If significant advancements can be achieved in elevating trauma patients' overall therapeutic outcomes and prognoses through continual improvement and optimization of alternative therapeutic modalities, it undoubtedly represents a collective and aspirational objective we all eagerly strive for. Li Deng, MDDepartment of Cardiovascular SurgeryGaozhou People's Hospital, GaozhouGuangdong, ChinaQingping Xia, MMCollege of Life Science, Mudanjiang Medical University, Mudanjiang CityHeilongjiang Province, ChinaLiangqing Zhang, MDDepartment of anesthesiologySecond Affiliated Hospital of Guangdong Medical University, ZhanjiangGuangdong Province, China

The Journal of Trauma: Injury, Infection, and Critical CareVol. 98(1)
Guangdong Medical College (CN), Second Affiliated Hospital of Guangzhou Medical University (CN), Mudanjiang Medical University (CN), Gaozhou People's Hospital (CN), Guangzhou Medical University (CN)
Openalex Percentile: Top 83%
Mechanical Circulatory Support Devices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.